Body-Clock Testing to Mitigate Health Risks of Night Work: A Prospective Cohort Study Protocol on Chronomedicine for Shift Workers
Article information
Abstract
Night-shift work is essential to modern industries but disrupts circadian rhythms, increasing risks of cardiometabolic disease, cancer, and mental health conditions. The International Agency for Research on Cancer (IARC) classifies “night-shift work involving circadian disruption” as “probably carcinogenic to humans” (Group 2A). Advances in chronobiology now enable precise estimation of internal circadian phase using transcriptomic, metabolomic, and wearable-based assessments. This protocol outlines a 24-month prospective cohort study evaluating the association between circadian misalignment and adverse health outcomes among 500 night-shift workers and 250 day-shift controls. Circadian phase will be assessed using multi-modal biomarkers and machine-learning models. Outcomes include metabolic, cardiovascular, inflammatory, and mental-health indicators. Mixed-effects regression models will examine longitudinal associations while adjusting for lifestyle and occupational covariates. The study aims to determine the feasibility of body-clock testing for personalized health interventions and improved shift-schedule design. Findings may inform occupational health policies and contribute to circadian-based preventive strategies for shift-dependent sectors.
INTRODUCTION
The hidden backbone of a 24-hour economy
Modern economies depend on a workforce that operates around the clock. Healthcare professionals, emergency responders, transportation operators, manufacturing personnel, security staff, and countless others ensure essential services continue when most of the population sleeps. This invisible infrastructure is vital for public safety, economic stability, and national security. Globally, between 15% and 30% of the workforce engages in shift work, with a significant proportion working night shifts [1]. In countries with advanced industrialization, these numbers can be even higher due to increasing demand for uninterrupted service provision and the rise of globalized business operations [2].
The cost of working against the clock
While the economic value of shift work is unquestionable, its cost to human health is profound. Epidemiological studies consistently reveal that night-shift workers experience higher rates of cardiovascular diseases (including hypertension, coronary artery disease, and stroke); metabolic disorders (particularly obesity, insulin resistance, and type 2 diabetes); mental health conditions (notably depression, anxiety, and burnout); and cancer (particularly breast and prostate cancer, with evidence supporting the role of circadian disruption in tumor progression) [3].
These risks stem from a mismatch between the body’s endogenous circadian rhythms and externally imposed work schedules. The resulting chronic misalignment leads to physiological stress, impaired metabolic regulation, immune dysregulation, and hormonal imbalance. In 2007, the International Agency for Research on Cancer (IARC) classified “shift work involving circadian disruption” as a probable human carcinogen (Group 2A) [4,5]. This classification underscores the seriousness of the health risks and the urgent need for preventive measures.
Circadian rhythms: nature’s timekeeper
The human circadian system is orchestrated by the suprachiasmatic nucleus (SCN) in the hypothalamus. The SCN receives light input from the retina, enabling synchronization of internal time with the external environment. Through neural and hormonal pathways, the SCN coordinates peripheral clocks in nearly every tissue, regulating daily patterns of sleep–wake cycles, core body temperature, hormone release (melatonin, cortisol), blood pressure, digestion, and cellular repair mechanisms [6-12]. In shift workers, light exposure at night and sleep during daylight hours disrupt these signals. Even if a worker adapts partially to a nocturnal schedule, social and environmental factors often prevent complete alignment, leading to a constant state of “social jet lag.”
Current limitations in managing shiftwork health
Traditional occupational health strategies like slow shift rotation, controlled lighting, or sleep hygiene education offer limited benefits because they overlook individual circadian variability. Workers differ in chronotype, light sensitivity, and adaptability, meaning a “one-size-fits-all” approach often fails. Similarly, medical interventions are frequently mistimed since they follow average circadian patterns; the effectiveness of drugs, vaccines, or even surgeries can vary with biological timing [13]. For shift workers whose internal clocks are delayed or advanced, such standard schedules may prove ineffective or even detrimental.
The promise of body clock testing
Advances in body clock testing, using transcriptomic, proteomic, and metabolomic profiling of blood, saliva, or other tissues, now enable precise estimation of circadian phase. In occupational settings, these tools can support personalized drug dosing, guide shift allocation, detect early disease risk, and optimize the timing of medical interventions to improve outcomes [14-16]. This paper reviews the science of circadian biology, assesses emerging testing technologies, and proposes strategies for their integration into occupational health to reduce the burden of shift work [17]. Supplementary Material 1 describes hypothetical circadian misalignment patterns expected among day-shift, night-shift, and rotating-shift workers.
LITERATURE REVIEW
Foundations of circadian biology
Circadian rhythms are endogenously generated cycles of approximately 24 hours, modulated by environmental cues known as zeitgebers (time givers). The most potent zeitgeber is light, but others include food intake, physical activity, and temperature. The molecular mechanism of circadian rhythms involves a transcription–translation feedback loop in which core clock genes (CLOCK, BMAL1, PER, CRY) regulate their own expression through protein feedback. These rhythms are not limited to the brain; peripheral clocks exist in the liver, pancreas, heart, and other organs, enabling tissue-specific timing of metabolic and physiological functions [18,19].
Health consequences of circadian disruption
When internal and external time are misaligned, as in shiftwork, the body’s systems become desynchronized. This misalignment has been linked to:
• Metabolic dysregulation: Animal studies show that eating during the biological night promotes weight gain and insulin resistance. Human studies confirm higher rates of metabolic syndrome among night-shift workers [20].
• Cardiovascular strain: Blood pressure and heart rate normally dip during sleep; night work reduces this “nocturnal dipping,” increasing strain on the cardiovascular system [21].
• Immune dysfunction: Immune cell trafficking and cytokine release follow circadian patterns; disruption impairs immune defense and may promote chronic inflammation [22].
• Cancer risk: Light at night suppresses melatonin, a hormone with anti-cancer properties. Circadian disruption also affects DNA repair mechanisms and cell cycle regulation [23].
Supplementary Tables 1-3 summarize predicted misalignment patterns and expected health differences. Table 1 summarizes the major health risks associated with circadian misalignment across key physiological domains.
Chronotherapy and time-dependent medicine
The field of chronomedicine aims to optimize the timing of medical interventions based on biological rhythms. Examples include the following:
• Antihypertensive drugs lowering blood pressure more effectively when taken at bedtime for certain patients.
• Chemotherapy shows improved tolerability and efficacy when scheduled to coincide with tumor cell susceptibility phases.
• Vaccinations produce stronger antibody responses in the morning versus the afternoon in some populations.
However, most chronotherapy research assumes a “standard” circadian phase, which may not apply to shift workers with altered internal time [24].
Current methods for measuring circadian phase
The gold standard for assessing circadian phase is dim-light melatonin onset (DLMO), measured from saliva or plasma samples collected under controlled lighting [25]. Other methods include: 1) actigraphy—wearable devices estimating sleep–wake patterns; 2) core body temperature profiling—continuous monitoring reveals circadian temperature minimum; and 3) cortisol rhythm analysis—using saliva or blood samples to detect peak and trough times. These methods, while useful, can be labor-intensive, intrusive, or insufficiently precise for clinical application (Table 2).
Emerging body clock testing technologies
Recent research has focused on high-throughput molecular assays, including the following: 1) transcriptomic signatures—measuring the expression of circadian-regulated genes from a single blood draw can estimate internal time to within 1–2 hours [26]; 2) metabolomic profiles—circadian variations in metabolites such as amino acids and lipids offer phase markers [4]; and 3) machine learning models—integrating wearable data (activity, light exposure, heart rate) with biomarker measurements for continuous circadian phase estimation [27]. Such tools are becoming cheaper and faster, enabling their potential integration into workplace health programs (Table 2).
METHODOLOGY PROPOSAL
Study design
To investigate the potential of body clock testing in mitigating shiftwork-related health risks, a prospective cohort study is proposed. The study will enroll 500 participants engaged in rotating or permanent night shifts across diverse industries such as healthcare, transportation, and manufacturing. A control group of 250 day-shift workers will also be recruited for comparative analysis. Participants will be monitored over a 24-month period to evaluate the relationship between circadian misalignment, measured via advanced body clock testing, and various health outcomes [28,29].
Recruitment and inclusion criteria
Eligible participants will be individuals who 1) are between 20 and 60 years of age; 2) have at least 6 months of continuous shiftwork history; 3) are not on long-term nightshift leave or extended sick leave at the time of recruitment; and 4) are willing to provide informed consent for biological sample collection and data monitoring.
Methods and analysis details
The primary endpoint is the degree of circadian misalignment, defined as the difference (in hours) between internal circadian phase (estimated by transcriptomic, metabolomic, and wearable-based assessments) and scheduled work time. We will also examine the association between circadian misalignment and metabolic outcomes (HbA1c, fasting glucose, lipid profile). The secondary endpoints encompass cardiovascular outcomes, mental health, and inflammatory outcomes. Cardiovascular outcomes include blood pressure (24-h profile), resting heart rate, and arterial stiffness (pulse wave velocity). Mental health will be assessed using validated questionnaires (Patient Health Questionnaire-9 [PHQ-9] for depression, Generalized Anxiety Disorder-7 [GAD-7] for anxiety, and Pittsburgh Sleep Quality Index [PSQI] for sleep quality). Inflammatory status will be evaluated through biomarkers such as high-sensitivity C-reactive protein (hs-CRP) and interleukin-6 (IL-6). Exploratory analyses will assess the feasibility of personalized scheduling recommendations based on circadian phase.
Sample size justification
Based on prior studies, a mean HbA1c difference of 0.4% between shift and day workers is clinically significant, with assumptions of a standard deviation (SD) of 1.2%, a two-sided α of 0.05, and 80% power. Under these assumptions, the required sample size is 430 shift workers and 215 controls. With 15% expected attention over 24 months, we plan to recruit 500 shift workers and 250 controls. This sample also provides >80% power to detect a 5 mm Hg difference in systolic BP (SD 12 mm Hg), 0.5 increase in PHQ-9 score (SD 1.5), and 0.3 mg/L difference in hs-CRP (SD 0.8).
Statistical analysis plan
The primary analysis will use mixed-effects regression models to evaluate the association between circadian misalignment and outcomes over time, with random interceptions for individuals. Covariates will include age, sex, BMI, smoking status, chronotype (morning/evening preference), industry type, and years of shiftwork. Adjusted models will account for socioeconomic status, baseline health status, and comorbidities. Subgroup analyses will compare permanent night, rotating shift, and day workers; as well as industry-specific effects across healthcare, manufacturing, and transportation. Sensitivity analyses will exclude participants with <70% follow-up data; and will explore alternative misalignment definitions (e.g., actigraphy-only vs. multimodal). The primary endpoint will be tested at α=0.05, while secondary outcomes will be interpreted with false discovery rate (FDR) correction for multiplicity. Missing data will be handled using multiple imputations by chained equations (MICE), assuming data are missing at random.
Quality assurance and monitoring
Quality assurance and monitoring procedures include 1) data monitoring: quarterly audits of data completeness and accuracy by an independent quality-monitoring committee; 2) wearable compliance: automated alerts will be sent if data gaps >12 h are detected; 3) bio sample handling: standard operating procedures for blood collection, RNA sequencing, metabolomics, and cold chain transport; and 4) adverse event reporting: minor risks include phlebotomy-related bruising or discomfort. All adverse events will be logged and reported to the IRB.
Data security and privacy
All data will be stored on encrypted institutional servers (AES-256). Participant IDs will be anonymized, and analysis datasets will contain no personally identifiable information. Access will be restricted to study investigators, and external data sharing will occur only after de-identification and ethical approval.
The overall study timeline, core design parameters, and the conceptual framework underlying comparisons across worker groups are summarized in Tables 3-5. Illustrative hypothetical results, predicted outcomes, and a case vignette derived from prior literature, rather than actual study data, are presented in the Supplementary Materials 1-5.
SPIRIT schedule outlining participant enrolment, interventions, and assessments over the 24-month study period
DISCUSSION
Interpretation of predicted findings
If confirmed, these results would demonstrate that circadian misalignment is not only measurable at the individual level but also modifiable through tailored interventions. Personalized body clock testing could transform shiftwork health management from reactive treatment to proactive prevention [29]. The literature indicates that circadian misalignment is both measurable and modifiable. If our results align with predictions in Supplementary Materials 2 and 3, body-clock testing could be incorporated into occupational health programs to personalize interventions.
Implications for chronotherapy
The application of precise circadian phase data to medical decision-making could significantly enhance drug efficacy and safety for shift workers. For example, chemotherapy could be administered when healthy tissue is most resilient, but tumor cells are most vulnerable. Similarly, statin therapy could be timed to coincide with peak cholesterol synthesis, and influenza vaccination could be scheduled to maximize antibody response. These interventions require accurate knowledge of everyone’s body time, which current generalized guidelines cannot provide [28,29].
Workplace integration strategies
To maximize benefit, body clock testing must be integrated into broader occupational health strategies [29]. Periodic testing should be conducted annually or semi-annually for all long-term shift workers. Adaptive scheduling algorithms may assign shifts based on compatibility with workers’ chronotypes and measured internal phases. Health monitoring should allow early intervention for workers showing signs of metabolic or cardiovascular strain. Finally, education and training for both workers and managers on circadian principles, light management, and sleep hygiene are essential to support these strategies.
Addressing challenges
Several barriers must be addressed before widespread implementation. Cost is an important consideration; while molecular testing prices are decreasing, initial adoption may be expensive. Employer subsidies or insurance coverage could be explored. Privacy is also critical, as circadian data is sensitive to health information, requiring robust safeguards and voluntary participation. Equity must be ensured to prevent the creation of a two-tier workforce where there is only some benefit from schedule adjustments. Finally, there is a potential risk of misuse: as with fitness trackers, there is a risk of the technology being used for non-clinical “optimization” by healthy individuals, diverting resources from those most in need [29].
Long-term vision
In the future, wearable sensors could provide continuous circadian phase estimation without invasive sampling, allowing real-time schedule adjustments. Integration with smart lighting, meal timing, and medication dispensers could create a closed-loop circadian health system for shift workers.
RECOMMENDATIONS
For employers, pilot programs should be implemented to test feasibility of circadian phase assessments in high-risk departments. Shift rosters should be designed to minimize abrupt changes and align with workers’ chronotypes, and employees should be provided access to appropriately timed meal and rest breaks. Healthcare providers are encouraged to incorporate circadian phase testing into occupational health checkups for shift workers. adjust medication timing to match individual body clocks; and educate patients on light exposure strategies to mitigate circadian disruption. For policymakers, circadian misalignment should be recognized as an occupational health hazard, and incentives should be provided for companies to adopt science-based scheduling practices. Additionally, funding should be allocated to support longitudinal studies on the long-term health effects of circadian-based interventions.
CONCLUSION
The “graveyard shift” is not merely a colloquialism; it reflects the serious health risks posed by working against the body’s natural rhythms. With the emergence of precise body clock testing technologies, we have an unprecedented opportunity to transform how we manage the health of shift workers. By aligning medical care, work schedules, and preventive measures with individual circadian profiles, it is possible to significantly reduce the burden of cardiovascular disease, metabolic disorders, cancer, and mental health issues in this essential workforce. Realizing this vision will require collaboration between scientists, employers, healthcare providers, and policymakers. If implemented ethically and equitably, chronomedicine for shift workers could not only save lives but also improve productivity and job satisfaction, offering a new lease of life for those who keep our 24-hour world running.
Supplementary Materials
The Supplement is available with this article at https://doi.org/10.33069/cim.2025.0051.
Hypothetical Patterns of Circadian Misalignment
Hypothetical Associations Between Circadian Misalignment and Health Outcomes
Simulation of Personalized Scheduling Benefits
Hypothetical Case Vignette
Interpretation of Predicted Outcomes
Notes
Ethics Statement
The study protocol was reviewed and approved by the Institutional Ethics Committee, Amity University, Lucknow (Approval No.: AUL/IEC/2025/037; Date: 10 October 2025).
The authors have no potential conflicts of interest to disclose.
Availability of Data and Material
Data generated in this study will be available upon reasonable request, following institutional ethics approval.
Author Contributions
Conceptualization: Devesh Ojha. Data curation: Devesh Ojha. Formal analysis: Devesh Ojha. Investigation: Devesh Ojha, Laxmi Ojha. Methodology: Devesh Ojha, Laxmi Ojha. Project administration: Devesh Ojha. Resources: Laxmi Ojha. Software: Devesh Ojha. Supervision: Laxmi Ojha. Validation: Devesh Ojha, Laxmi Ojha. Visualization: Devesh Ojha. Writing—original draft: Devesh Ojha. Writing—review & editing: Laxmi Ojha.
Funding Statement
None
Acknowledgments
The authors thank Amity University, Lucknow, and the Military Nursing Service for institutional support.
The study has been submitted to the Clinical Trials Registry–India (CTRI) and is currently under review (Reference No.: REF/2025/10/019789).
